FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

Clinical trial NCT00424866 · NOT_YET_RECRUITING

Trial details

NCT number: NCT00424866
Sponsor: Venturis Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral Arterial Disease Stenosis Intermittent Claudication

Start date: 2028-10-15
Primary completion: 2030-02-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.